Is Mycological Society Of America The Legit?

The Mycological Society Of America The demonstrates consistent financial health, maintaining a strong asset base relative to its annual revenue. For instance, in 2021, with revenue of $233,916, its assets stood at $2,596,407, indicating robust financial reserves. The organization consistently spends less than it earns, as seen in 2021 where expenses were $139,221 against $233,916 in revenue, contributing to asset growth over time. This prudent financial management suggests a sustainable operational model. The organization's spending efficiency appears high, with a significant portion of its expenses likely directed towards its programmatic mission, given the absence of reported officer compensation across all filings. This suggests a lean operational structure. While a detailed functional expense breakdown is not provided in the summary data, the consistent positive net income and asset growth imply effective resource allocation. The lack of reported officer compensation also points to a high degree of transparency regarding executive pay, as it indicates either a volunteer-led executive team or compensation below reporting thresholds, which is a positive sign for a nonprofit of this size. Overall, the Mycological Society Of America The exhibits strong financial stewardship. Its consistent asset growth, low liabilities, and absence of reported officer compensation across multiple years reflect a well-managed and transparent organization. The financial data suggests a focus on accumulating reserves, which provides stability and long-term sustainability for its mission.